Definitive Contract HT942525CE008
- Not listed
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Tao Treasures, LLC, doing business as Nanobiofab, for development of TRISENSE, an artificially intelligent volatile organic compound sensing system designed for culture-free infection diagnosis in biofluids. This total small business set-aside contract, awarded on September 15, 2025, represents a continuation of the SBIR program's support for innovative medical technologies and is...
- The Department of the Army Medical Command awarded a $249,977.35 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Tao Treasures, LLC, doing business as Nanobiofab, a minority-owned, self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company located in Frederick, Maryland. The contract, funded under the Defense Health Agency's SBIR program, is for research and development of a "RAPID-INOSE:...
- The Department of the Army Medical Command awarded a $1,099,999.67 definitive contract to Tao Treasures, LLC, doing business as Nanobiofab, for work on Rapid-INOSE: Real-Time Agnostic Patch for Infection Detection Using Intelligent Nose under the Small Business Innovation Research Program Phase II solicitation. The contract is set aside for total small business and will support research and development efforts through December 2025 to deliver a rapid, agnostic patch for infection detection using...
- The Defense Health Agency awarded a $1.30 million Small Business Innovation Research (SBIR) Phase II contract to Tao Treasures, LLC (doing business as Nanobiofab) on September 15, 2025, for development of EyeSense, an artificial intelligence-powered volatile organic compound nanosensor integrated autonomous real-time monitoring system designed for ocular injury management. The contract, which carries a firm fixed price and is set aside for total small business, extends through January 14,...
- Tao Treasures, LLC, doing business as Nanobiofab, has been awarded a firm fixed price Small Business Innovation Research Program Phase I contract valued at $249,963 from the Defense Health Agency. The award will support research titled "Inkjet Assisted Nano Printing Sensing Platform for High Throughput Flexible Sensors Discovery" under SBIR topic number H201-003-0047. As a minority-owned, self-certified small disadvantaged woman-owned business, Tao Treasures will utilize the funding to...
- The Defense Health Agency has awarded a $249,962.26 Small Business Innovation Research (SBIR) Phase I contract to Applied Nanotech, Inc., doing business as Fepet, for the development of MicroBeID, a point-of-care, electronics-free molecular diagnostic platform for microbial detection. The contract, issued as a firm fixed-price purchase order with an ultimate completion date of March 21, 2026, is designated as a total small business set-aside and supports medical research and development...
- This is a $1,871,326.84 firm fixed price Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Tao Treasures, LLC, doing business as Nanobiofab. Nanobiofab is a minority-owned, self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company located in Frederick, Maryland. The contract is for the development of "WoundSentry," an integrated smart dressing for...
- Tao Treasures, LLC, doing business as Nanobiofab, has been awarded a $1.6 million firm fixed price contract from the Department of the Army Medical Command to deliver on Phase II of proposal H2-0643 titled "AI-Powered Inkjet Assisted Nano Printing and Screening Platform for High-Throughput Flexible Sensors Discovery." The research will be conducted under the Small Business Innovation Research Program Phase II vehicle. Work will take place in Frederick, Maryland through December 2024....
- The U.S. Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for $149,987.00. The contract is for a "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES". This is a firm-fixed-price, definitive contract with a period of performance ending on November 30, 2017. The contract was...
- This is a Small Business Innovation Research (STTR) Phase I contract awarded by the Defense Health Agency to Innosense Corporation, a minority-owned, economically disadvantaged women-owned small business. The $162,499.11 fixed-price contract is for research and development on a multi-functional nanotube-based sensor array to detect blood coagulation defects. The research aims to advance medical diagnostic capabilities relevant to the Defense Health Agency's mission. Innosense has a history of...
The Defense Health Agency awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Tao Treasures, LLC, doing business as Nanobiofab, on September 5, 2025. The contract, designated as a Total Small Business set-aside, supports development of Rapid-INOSE, a next-generation intelligent diagnostic platform designed to enable precision infection management through broad-spectrum volatile organic compound (VOC) sensing and artificial intelligence. The work is scheduled for completion by January 4, 2028, and will be performed in Frederick, Maryland. Nanobiofab is a minority-owned, woman-owned, and Asian-Pacific American-owned small disadvantaged business specializing in advanced medical research and development with a focus on innovative sensing and diagnostic technologies. The company has previously secured over $5 million in federal contracts from the Defense Health Agency and Department of the Army Medical Command through the SBIR program, developing technologies such as WoundSentry, an intelligent smart dressing for burn wound infection detection. This Phase II award represents a continuation of the company's work in non-invasive diagnostic tools and intelligent sensor platforms that leverage artificial intelligence and nanotechnology for healthcare applications within the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 8/26/25 |